Aromatase, aromatase inhibitors, and breast cancer

This publication has 103 references indexed in Scilit:

• X-ray structure of human aromatase reveals an androgen-specific active site
  The Journal of Steroid Biochemistry and Molecular Biology, 2009
• Biological determinants of endocrine resistance in breast cancer
  Nature Reviews Cancer, 2009
• Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
  New England Journal of Medicine, 2009
• Structural basis for androgen specificity and oestrogen synthesis in human aromatase
  Nature, 2009
• Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
  The Lancet Oncology, 2008
• Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
  The Lancet, 2007
• Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer
  Steroids, 2006
• Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling
  Oncogene, 2003
• Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera
  Oncogene, 2002
• ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1
  The Lancet, 1896